Global Disease Management Software

Disease Management Software Comprehensive Study by Application (Hospitals, Clinics), Functionality (Care Authorization, Lab Test Review, Treatment Planning), Subscription (Monthly Subscription, Annual Subscription, One-Time License), Deployment Model (On-Premise, Web-Based) Players and Region - Global Market Outlook to 2028

Disease Management Software Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Disease Management Software
Disease management software is constructed to connect with EHR and different fitness care statistics reassets to manipulate, monitor, and system affected person statistics. Disease control software is utilized by hospitals, clinics, and different fitness care practices to engage, educate, and deal with patients. Disease management software, additionally referred to as care control or persistent disease control software optimizes and connects care procedures to efficaciously manage ongoing fitness conditions. Disease control software automates and simplifies complicated responsibilities consisting of follow-up care authorization, lab check review, and remedy planning.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Disease Management Software market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

emr4MD (United States), Conduent Care Management (United States), Altruista Health (United States), HealthViewX Chronic Care Management (United States), HUMHEALTH (United States), Lark (United States), LexisNexis Socioeconomic Health Attributes (United States), Omada Health (United States), Pega Care Management (United States) and Periwatch Viligance (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are ACUITY Advanced Care (United States), Avedon Health Systems (United States) and Welldoc (United States).

Segmentation Overview
AMA Research has segmented the market of Global Disease Management Software market by , Application (Hospitals and Clinics) and Region.



On the basis of geography, the market of Disease Management Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Functionality, the sub-segment i.e. Care Authorization will boost the Disease Management Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Subscription, the sub-segment i.e. Monthly Subscription will boost the Disease Management Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Deployment Model, the sub-segment i.e. On-Premise will boost the Disease Management Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Integration Of Technologies Such As Artificial Intelligence And Machine Learning

Market Growth Drivers:
Increase in demand of Remote Patient Monitoring (RPM) in hospital

Challenges:
Networks and Computers have Various Maintenance Issues and Lack of Techniques for Data Entry and Retrieval

Restraints:
Lack of Support from Medical Professionals, Motivation, and More and Technical Challenges in Teaching Users to Use the Software

Opportunities:
Growing the adoption of disease management software in health sector

Market Leaders and their expansionary development strategies
In November 2022, ResMed announced it has completed its USD 958.6 million acquisition of MEDIFOX DAN, a German leader in software solutions for a wide variety of out-of-hospital care providers. MEDIFOX DAN is headquartered in Hildesheim, Germany, with over 700 employees. It now operates under its current brand within the ResMed SaaS business segment.
In January 2019Conduent Incorporated announced it has completed its acquisition of Health Solutions Plus (HSP), a software provider of healthcare payer administration solutions.The acquisition enables Conduent to better serve current and prospective commercial and government payer clients with core administration processing technology. In particular, with the purchase of HSP, Conduent offers a modern Core Administration Processing System (CAPS) solution, which is a key connector of administrative functions for healthcare funding entities, including commercial payers, managed care organizations, state Medicaid agencies and Medicare Advantage payers.


Key Target Audience
Disease Management Software developer, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Hospitals
  • Clinics
By Functionality
  • Care Authorization
  • Lab Test Review
  • Treatment Planning

By Subscription
  • Monthly Subscription
  • Annual Subscription
  • One-Time License

By Deployment Model
  • On-Premise
  • Web-Based

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in demand of Remote Patient Monitoring (RPM) in hospital
    • 3.3. Market Challenges
      • 3.3.1. Networks and Computers have Various Maintenance Issues
      • 3.3.2. Lack of Techniques for Data Entry and Retrieval
    • 3.4. Market Trends
      • 3.4.1. Integration Of Technologies Such As Artificial Intelligence And Machine Learning
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Disease Management Software, by Application, Functionality, Subscription, Deployment Model and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Disease Management Software (Value)
      • 5.2.1. Global Disease Management Software by: Application (Value)
        • 5.2.1.1. Hospitals
        • 5.2.1.2. Clinics
      • 5.2.2. Global Disease Management Software by: Functionality (Value)
        • 5.2.2.1. Care Authorization
        • 5.2.2.2. Lab Test Review
        • 5.2.2.3. Treatment Planning
      • 5.2.3. Global Disease Management Software by: Subscription (Value)
        • 5.2.3.1. Monthly Subscription
        • 5.2.3.2. Annual Subscription
        • 5.2.3.3. One-Time License
      • 5.2.4. Global Disease Management Software by: Deployment Model (Value)
        • 5.2.4.1. On-Premise
        • 5.2.4.2. Web-Based
      • 5.2.5. Global Disease Management Software Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Disease Management Software: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Emr4MD (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Conduent Care Management (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Altruista Health (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. HealthViewX Chronic Care Management (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. HUMHEALTH (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Lark (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. LexisNexis Socioeconomic Health Attributes (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Omada Health (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pega Care Management (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Periwatch Viligance (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Disease Management Software Sale, by Application, Functionality, Subscription, Deployment Model and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Disease Management Software (Value)
      • 7.2.1. Global Disease Management Software by: Application (Value)
        • 7.2.1.1. Hospitals
        • 7.2.1.2. Clinics
      • 7.2.2. Global Disease Management Software by: Functionality (Value)
        • 7.2.2.1. Care Authorization
        • 7.2.2.2. Lab Test Review
        • 7.2.2.3. Treatment Planning
      • 7.2.3. Global Disease Management Software by: Subscription (Value)
        • 7.2.3.1. Monthly Subscription
        • 7.2.3.2. Annual Subscription
        • 7.2.3.3. One-Time License
      • 7.2.4. Global Disease Management Software by: Deployment Model (Value)
        • 7.2.4.1. On-Premise
        • 7.2.4.2. Web-Based
      • 7.2.5. Global Disease Management Software Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Disease Management Software: by Application(USD Million)
  • Table 2. Disease Management Software Hospitals , by Region USD Million (2017-2022)
  • Table 3. Disease Management Software Clinics , by Region USD Million (2017-2022)
  • Table 4. Disease Management Software: by Functionality(USD Million)
  • Table 5. Disease Management Software Care Authorization , by Region USD Million (2017-2022)
  • Table 6. Disease Management Software Lab Test Review , by Region USD Million (2017-2022)
  • Table 7. Disease Management Software Treatment Planning , by Region USD Million (2017-2022)
  • Table 8. Disease Management Software: by Subscription(USD Million)
  • Table 9. Disease Management Software Monthly Subscription , by Region USD Million (2017-2022)
  • Table 10. Disease Management Software Annual Subscription , by Region USD Million (2017-2022)
  • Table 11. Disease Management Software One-Time License , by Region USD Million (2017-2022)
  • Table 12. Disease Management Software: by Deployment Model(USD Million)
  • Table 13. Disease Management Software On-Premise , by Region USD Million (2017-2022)
  • Table 14. Disease Management Software Web-Based , by Region USD Million (2017-2022)
  • Table 15. South America Disease Management Software, by Country USD Million (2017-2022)
  • Table 16. South America Disease Management Software, by Application USD Million (2017-2022)
  • Table 17. South America Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 18. South America Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 19. South America Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 20. Brazil Disease Management Software, by Application USD Million (2017-2022)
  • Table 21. Brazil Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 22. Brazil Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 23. Brazil Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 24. Argentina Disease Management Software, by Application USD Million (2017-2022)
  • Table 25. Argentina Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 26. Argentina Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 27. Argentina Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 28. Rest of South America Disease Management Software, by Application USD Million (2017-2022)
  • Table 29. Rest of South America Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 30. Rest of South America Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 31. Rest of South America Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 32. Asia Pacific Disease Management Software, by Country USD Million (2017-2022)
  • Table 33. Asia Pacific Disease Management Software, by Application USD Million (2017-2022)
  • Table 34. Asia Pacific Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 35. Asia Pacific Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 36. Asia Pacific Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 37. China Disease Management Software, by Application USD Million (2017-2022)
  • Table 38. China Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 39. China Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 40. China Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 41. Japan Disease Management Software, by Application USD Million (2017-2022)
  • Table 42. Japan Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 43. Japan Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 44. Japan Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 45. India Disease Management Software, by Application USD Million (2017-2022)
  • Table 46. India Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 47. India Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 48. India Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 49. South Korea Disease Management Software, by Application USD Million (2017-2022)
  • Table 50. South Korea Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 51. South Korea Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 52. South Korea Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 53. Taiwan Disease Management Software, by Application USD Million (2017-2022)
  • Table 54. Taiwan Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 55. Taiwan Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 56. Taiwan Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 57. Australia Disease Management Software, by Application USD Million (2017-2022)
  • Table 58. Australia Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 59. Australia Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 60. Australia Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 61. Rest of Asia-Pacific Disease Management Software, by Application USD Million (2017-2022)
  • Table 62. Rest of Asia-Pacific Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 65. Europe Disease Management Software, by Country USD Million (2017-2022)
  • Table 66. Europe Disease Management Software, by Application USD Million (2017-2022)
  • Table 67. Europe Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 68. Europe Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 69. Europe Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 70. Germany Disease Management Software, by Application USD Million (2017-2022)
  • Table 71. Germany Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 72. Germany Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 73. Germany Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 74. France Disease Management Software, by Application USD Million (2017-2022)
  • Table 75. France Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 76. France Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 77. France Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 78. Italy Disease Management Software, by Application USD Million (2017-2022)
  • Table 79. Italy Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 80. Italy Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 81. Italy Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 82. United Kingdom Disease Management Software, by Application USD Million (2017-2022)
  • Table 83. United Kingdom Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 84. United Kingdom Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 85. United Kingdom Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 86. Netherlands Disease Management Software, by Application USD Million (2017-2022)
  • Table 87. Netherlands Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 88. Netherlands Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 89. Netherlands Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 90. Rest of Europe Disease Management Software, by Application USD Million (2017-2022)
  • Table 91. Rest of Europe Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 92. Rest of Europe Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 93. Rest of Europe Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 94. MEA Disease Management Software, by Country USD Million (2017-2022)
  • Table 95. MEA Disease Management Software, by Application USD Million (2017-2022)
  • Table 96. MEA Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 97. MEA Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 98. MEA Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 99. Middle East Disease Management Software, by Application USD Million (2017-2022)
  • Table 100. Middle East Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 101. Middle East Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 102. Middle East Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 103. Africa Disease Management Software, by Application USD Million (2017-2022)
  • Table 104. Africa Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 105. Africa Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 106. Africa Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 107. North America Disease Management Software, by Country USD Million (2017-2022)
  • Table 108. North America Disease Management Software, by Application USD Million (2017-2022)
  • Table 109. North America Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 110. North America Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 111. North America Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 112. United States Disease Management Software, by Application USD Million (2017-2022)
  • Table 113. United States Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 114. United States Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 115. United States Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 116. Canada Disease Management Software, by Application USD Million (2017-2022)
  • Table 117. Canada Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 118. Canada Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 119. Canada Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 120. Mexico Disease Management Software, by Application USD Million (2017-2022)
  • Table 121. Mexico Disease Management Software, by Functionality USD Million (2017-2022)
  • Table 122. Mexico Disease Management Software, by Subscription USD Million (2017-2022)
  • Table 123. Mexico Disease Management Software, by Deployment Model USD Million (2017-2022)
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Disease Management Software: by Application(USD Million)
  • Table 135. Disease Management Software Hospitals , by Region USD Million (2023-2028)
  • Table 136. Disease Management Software Clinics , by Region USD Million (2023-2028)
  • Table 137. Disease Management Software: by Functionality(USD Million)
  • Table 138. Disease Management Software Care Authorization , by Region USD Million (2023-2028)
  • Table 139. Disease Management Software Lab Test Review , by Region USD Million (2023-2028)
  • Table 140. Disease Management Software Treatment Planning , by Region USD Million (2023-2028)
  • Table 141. Disease Management Software: by Subscription(USD Million)
  • Table 142. Disease Management Software Monthly Subscription , by Region USD Million (2023-2028)
  • Table 143. Disease Management Software Annual Subscription , by Region USD Million (2023-2028)
  • Table 144. Disease Management Software One-Time License , by Region USD Million (2023-2028)
  • Table 145. Disease Management Software: by Deployment Model(USD Million)
  • Table 146. Disease Management Software On-Premise , by Region USD Million (2023-2028)
  • Table 147. Disease Management Software Web-Based , by Region USD Million (2023-2028)
  • Table 148. South America Disease Management Software, by Country USD Million (2023-2028)
  • Table 149. South America Disease Management Software, by Application USD Million (2023-2028)
  • Table 150. South America Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 151. South America Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 152. South America Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 153. Brazil Disease Management Software, by Application USD Million (2023-2028)
  • Table 154. Brazil Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 155. Brazil Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 156. Brazil Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 157. Argentina Disease Management Software, by Application USD Million (2023-2028)
  • Table 158. Argentina Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 159. Argentina Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 160. Argentina Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 161. Rest of South America Disease Management Software, by Application USD Million (2023-2028)
  • Table 162. Rest of South America Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 163. Rest of South America Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 164. Rest of South America Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 165. Asia Pacific Disease Management Software, by Country USD Million (2023-2028)
  • Table 166. Asia Pacific Disease Management Software, by Application USD Million (2023-2028)
  • Table 167. Asia Pacific Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 168. Asia Pacific Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 169. Asia Pacific Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 170. China Disease Management Software, by Application USD Million (2023-2028)
  • Table 171. China Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 172. China Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 173. China Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 174. Japan Disease Management Software, by Application USD Million (2023-2028)
  • Table 175. Japan Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 176. Japan Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 177. Japan Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 178. India Disease Management Software, by Application USD Million (2023-2028)
  • Table 179. India Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 180. India Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 181. India Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 182. South Korea Disease Management Software, by Application USD Million (2023-2028)
  • Table 183. South Korea Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 184. South Korea Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 185. South Korea Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 186. Taiwan Disease Management Software, by Application USD Million (2023-2028)
  • Table 187. Taiwan Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 188. Taiwan Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 189. Taiwan Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 190. Australia Disease Management Software, by Application USD Million (2023-2028)
  • Table 191. Australia Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 192. Australia Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 193. Australia Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 194. Rest of Asia-Pacific Disease Management Software, by Application USD Million (2023-2028)
  • Table 195. Rest of Asia-Pacific Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 196. Rest of Asia-Pacific Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 197. Rest of Asia-Pacific Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 198. Europe Disease Management Software, by Country USD Million (2023-2028)
  • Table 199. Europe Disease Management Software, by Application USD Million (2023-2028)
  • Table 200. Europe Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 201. Europe Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 202. Europe Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 203. Germany Disease Management Software, by Application USD Million (2023-2028)
  • Table 204. Germany Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 205. Germany Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 206. Germany Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 207. France Disease Management Software, by Application USD Million (2023-2028)
  • Table 208. France Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 209. France Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 210. France Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 211. Italy Disease Management Software, by Application USD Million (2023-2028)
  • Table 212. Italy Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 213. Italy Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 214. Italy Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 215. United Kingdom Disease Management Software, by Application USD Million (2023-2028)
  • Table 216. United Kingdom Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 217. United Kingdom Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 218. United Kingdom Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 219. Netherlands Disease Management Software, by Application USD Million (2023-2028)
  • Table 220. Netherlands Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 221. Netherlands Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 222. Netherlands Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 223. Rest of Europe Disease Management Software, by Application USD Million (2023-2028)
  • Table 224. Rest of Europe Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 225. Rest of Europe Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 226. Rest of Europe Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 227. MEA Disease Management Software, by Country USD Million (2023-2028)
  • Table 228. MEA Disease Management Software, by Application USD Million (2023-2028)
  • Table 229. MEA Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 230. MEA Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 231. MEA Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 232. Middle East Disease Management Software, by Application USD Million (2023-2028)
  • Table 233. Middle East Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 234. Middle East Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 235. Middle East Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 236. Africa Disease Management Software, by Application USD Million (2023-2028)
  • Table 237. Africa Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 238. Africa Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 239. Africa Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 240. North America Disease Management Software, by Country USD Million (2023-2028)
  • Table 241. North America Disease Management Software, by Application USD Million (2023-2028)
  • Table 242. North America Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 243. North America Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 244. North America Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 245. United States Disease Management Software, by Application USD Million (2023-2028)
  • Table 246. United States Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 247. United States Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 248. United States Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 249. Canada Disease Management Software, by Application USD Million (2023-2028)
  • Table 250. Canada Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 251. Canada Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 252. Canada Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 253. Mexico Disease Management Software, by Application USD Million (2023-2028)
  • Table 254. Mexico Disease Management Software, by Functionality USD Million (2023-2028)
  • Table 255. Mexico Disease Management Software, by Subscription USD Million (2023-2028)
  • Table 256. Mexico Disease Management Software, by Deployment Model USD Million (2023-2028)
  • Table 257. Research Programs/Design for This Report
  • Table 258. Key Data Information from Secondary Sources
  • Table 259. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Disease Management Software: by Application USD Million (2017-2022)
  • Figure 5. Global Disease Management Software: by Functionality USD Million (2017-2022)
  • Figure 6. Global Disease Management Software: by Subscription USD Million (2017-2022)
  • Figure 7. Global Disease Management Software: by Deployment Model USD Million (2017-2022)
  • Figure 8. South America Disease Management Software Share (%), by Country
  • Figure 9. Asia Pacific Disease Management Software Share (%), by Country
  • Figure 10. Europe Disease Management Software Share (%), by Country
  • Figure 11. MEA Disease Management Software Share (%), by Country
  • Figure 12. North America Disease Management Software Share (%), by Country
  • Figure 13. Global Disease Management Software share by Players 2022 (%)
  • Figure 14. Global Disease Management Software share by Players (Top 3) 2022(%)
  • Figure 15. Global Disease Management Software share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Emr4MD (United States) Revenue, Net Income and Gross profit
  • Figure 18. Emr4MD (United States) Revenue: by Geography 2022
  • Figure 19. Conduent Care Management (United States) Revenue, Net Income and Gross profit
  • Figure 20. Conduent Care Management (United States) Revenue: by Geography 2022
  • Figure 21. Altruista Health (United States) Revenue, Net Income and Gross profit
  • Figure 22. Altruista Health (United States) Revenue: by Geography 2022
  • Figure 23. HealthViewX Chronic Care Management (United States) Revenue, Net Income and Gross profit
  • Figure 24. HealthViewX Chronic Care Management (United States) Revenue: by Geography 2022
  • Figure 25. HUMHEALTH (United States) Revenue, Net Income and Gross profit
  • Figure 26. HUMHEALTH (United States) Revenue: by Geography 2022
  • Figure 27. Lark (United States) Revenue, Net Income and Gross profit
  • Figure 28. Lark (United States) Revenue: by Geography 2022
  • Figure 29. LexisNexis Socioeconomic Health Attributes (United States) Revenue, Net Income and Gross profit
  • Figure 30. LexisNexis Socioeconomic Health Attributes (United States) Revenue: by Geography 2022
  • Figure 31. Omada Health (United States) Revenue, Net Income and Gross profit
  • Figure 32. Omada Health (United States) Revenue: by Geography 2022
  • Figure 33. Pega Care Management (United States) Revenue, Net Income and Gross profit
  • Figure 34. Pega Care Management (United States) Revenue: by Geography 2022
  • Figure 35. Periwatch Viligance (United States) Revenue, Net Income and Gross profit
  • Figure 36. Periwatch Viligance (United States) Revenue: by Geography 2022
  • Figure 37. Global Disease Management Software: by Application USD Million (2023-2028)
  • Figure 38. Global Disease Management Software: by Functionality USD Million (2023-2028)
  • Figure 39. Global Disease Management Software: by Subscription USD Million (2023-2028)
  • Figure 40. Global Disease Management Software: by Deployment Model USD Million (2023-2028)
  • Figure 41. South America Disease Management Software Share (%), by Country
  • Figure 42. Asia Pacific Disease Management Software Share (%), by Country
  • Figure 43. Europe Disease Management Software Share (%), by Country
  • Figure 44. MEA Disease Management Software Share (%), by Country
  • Figure 45. North America Disease Management Software Share (%), by Country
List of companies from research coverage that are profiled in the study
  • emr4MD (United States)
  • Conduent Care Management (United States)
  • Altruista Health (United States)
  • HealthViewX Chronic Care Management (United States)
  • HUMHEALTH (United States)
  • Lark (United States)
  • LexisNexis Socioeconomic Health Attributes (United States)
  • Omada Health (United States)
  • Pega Care Management (United States)
  • Periwatch Viligance (United States)
Additional players considered in the study are as follows:
ACUITY Advanced Care (United States) , Avedon Health Systems (United States) , Welldoc (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 231 Pages 80 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Disease Management Software Quantitative research analysis
Global Disease Management Software Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as emr4MD (United States), Conduent Care Management (United States), Altruista Health (United States), HealthViewX Chronic Care Management (United States), HUMHEALTH (United States), Lark (United States), LexisNexis Socioeconomic Health Attributes (United States), Omada Health (United States), Pega Care Management (United States) and Periwatch Viligance (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Integration Of Technologies Such As Artificial Intelligence And Machine Learning" is seen as one of major influencing trends for Disease Management Software Market during projected period 2022-2028.
The Disease Management Software market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Disease Management Software Report?

Have a Query? Click Here

Other Related Reports

Programmatic Advertising Platform Comprehensive Study by Application (Governance, Commerical, Others), Ad Format (Desktop Display, Desktop Video, Mobile Display, Mobile Video), Transaction Mode (Real...
$ 3650
Golf Software Comprehensive Study by Type (Basic, Standard, Senior), Application (Private Golf Club, Semi-Private Golf Club, Public Golf Club), Deployment Mode (Cloud Based, Web Based), End User (Gol...
$ 3350
Insurance Analytics Software Comprehensive Study by Deployment Mode (Cloud-Based, On-premises), Organization Size (Small and Medium-Sized Enterprises, Large Enterprises), End User (Insurance Companie...
$ 3450
Data Privacy Software Comprehensive Study by Application (Large Size Enterprises, Small-medium Size Enterprises), Pricing Option (Monthly Subscription, Annual Subscription, One-Time License), Deploym...
$ 3650
Day Trading Software Comprehensive Study by Application (Personal Use, Small-medium Size Enterprise, Large Size Enterprises), Platform (Windows, Mac, Android, IOS), Deployment (Cloud-based, On-premis...
$ 3450
Remote Access Management Comprehensive Study by Organization Size (SME’s, Large Enterprises), Technology (IPSec VPN, SSL VPN, Direct Access), Industry Vertical (BFSI, Manufacturing, Healthcare, IT & ...
$ 3450